PicnicHealth has the ability to access all medical records in the US for consented study participants
Reduce time to the start of recruitment to as low as 4 weeks
PicnicStudies is an adaptive platform that captures complete patient journeys through smart and nimble study execution.
Through a direct-to-patient approach, PicnicStudies ensures that each patient’s past and future healthcare interactions and experiences are captured for the clinically-rich evidence you need.
These patient relationships, along with our scientific expertise and virtual and hybrid technologies, means no more data gaps, loss to follow up, and complex site contracts, resulting in more efficient studies.
Curated from an average of 10+ healthcare locations and 50+ clinical encounters per patient, retrospectively and prospectively.
Direct-to-patient platform for validated and custom patient reported outcomes that has a 70% survey response rate.
Linkage to additional data modalities, including claims and images.
Reduce time to the start of recruitment to as low as 4 weeks, with a central IRB and virtual site capabilities that minimize time-consuming start-up activities.
Instantly trigger recruitment across our 40+ partners to enable more diverse patient representation. Without being restricted by specific site networks or EHR platforms, we have access to all patients in the U.S.
Reduce burden on your sites through a platform for patient eligibility verification and limiting the amount of data that needs to be manually collected, with PicnicHealth retrieving the majority of the data directly from medical records.
Reduce patient attrition to less than 1% year-over-year, by arming patients with their complete health records and providing them with long-term value.
Incorporate new data elements into existing studies or conduct new sub-studies faster than ever before with access to source data and narrative text insights.
Work with research partners to design studies around their goals, including determining data modalities, recruitment methods, and site involvement.
Recruit patients across the U.S. through 40+ partners. Patients sign up, are screened, and consent in a 5 minute onboarding process.
Collect 5-7 years of retrospective data, and continue collecting prospective data across all sites independent of changes to providers, insurers, or health systems. Capture primary data through PROs and virtual site capabilities.
Abstract clinically relevant data with robust quality management processes. Depending on partners’ needs, data is analyzed in preparation for submission for publication or for regulatory use.
Methods of Estimating Annualized Bleed Rates from Medical Records Among Patients with Hemophilia A
Methods of Estimating Annualized Bleed Rates from Medical Records Among Patients with Hemophilia A
Historically, the life sciences industry has leveraged a limited set of real-world data (RWD) and real-world evidence (RWE) options to support a narrower scope of typically enabling access and post-marketing support.
Historically, the life sciences industry has leveraged a limited set of real-world data (RWD) and real-world evidence (RWE) options to support a narrower scope of typically enabling access and post-marketing support.
A Fully Enrolled, Novel, Patient-Centred Real-World Evidence Study Designed to Better Understand Active and Nonactive Progressive Multiple Sclerosis Using Health Records in the United States
A Fully Enrolled, Novel, Patient-Centred Real-World Evidence Study Designed to Better Understand Active and Nonactive Progressive Multiple Sclerosis Using Health Records in the United States
With more individuals surviving cancer, it is critical that the health care community is able to understand the full journey of a patient with cancer – from early signs that something is amiss, through diagnosis, treatment, and long-term survival.
Through our partnership with PicnicHealth, we hope to better understand the full patient experience, address new research questions, and ultimately improve patient outcomes and the overall experience of people with cancer.
